WHO ICTRP trial
Vitamin B6 in the treatment of akathisia
IRCT201111042935N6 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT201111042935N6 |
|---|---|
| Public title | Vitamin B6 in the treatment of akathisia |
| Scientific title | Effect of Vitamin B6 versus propranolol in patients with neuroleptic -induced Akathisia : ?A randomized-double blind study |
| Primary sponsor | Vice chancellor for research, Kurdistan University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Phase | 2-3 |
| Countries | Iran (Islamic Republic of) |
| Conditions | medication-induced acute akathisia. Other extrapyramidal and movement disorders;Other extrapyramidal and movement disorders |
| Interventions | Intervention 1: vitamin B6 600 mg per day for 5 days. Intervention 2: vitamin B6 1200 mg per day for 5 days. Intervention 3: propranolol 40 mg per day for 5 days.;Treatment - Drugs;Treatment - Drugs;Treatment - Drugs;vitamin B6 600 mg per… |
| Registration date | Feb 18, 2012 |
| Target size | 51 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: